Malignant pleural effusion facilitates the establishment and maintenance of tumor organoid biobank with multiple patient-derived lung tumor cell sources
Abstract The Patient-Derived Organoids (PDOs) has demonstrated significant potential in personalized medicine. However, the initial establishment of lung cancer organoids (LCOs), and timely therapeutic recommendations face several challenges. Particularly, the current culture systems have not yet ac...
Saved in:
| Main Authors: | Lingwei Wang, Yanli Yu, Yanhua Fang, Yanjiao Li, Weiting Yu, Zhe Wang, Jinyan Lv, Ruoyu Wang, Shanshan Liang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Experimental Hematology & Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40164-024-00581-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Droplet-engineered organoids recapitulate parental tissue transcriptome with inter-organoid homogeneity and inter-tumor cell heterogeneity
by: Haoran Zhao, et al.
Published: (2024-11-01) -
Cholangiocyte organoids for disease, cancer, and regenerative medicine
by: Munemasa Nagao, et al.
Published: (2025-03-01) -
Revolutionizing cardiovascular research: Human organoids as a Beacon of hope for understanding and treating cardiovascular diseases
by: Jinli Li, et al.
Published: (2025-02-01) -
Tunneled pleural catheter in pleural effusion: To Whom? When? How?
by: Raquel Martínez-Tomás, et al.
Published: (2024-10-01) -
Protocol for generating a pancreatic cancer organoid associated with heterogeneous tumor microenvironment
by: Kenta Takeuchi, et al.
Published: (2025-03-01)